Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Alveolar Soft Part × anlotinib × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 2 Whole-Brain Radiotherapy 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Leiomyosarcoma 1 Carcinoma, Renal Cell 1

Interventions

atezolizumab 2 selinexor 1 pazopanib 1 anlotinib 1 Zoledronic Acid 1 Tablets 1 Specimen Handling 1 Rosuvastatin Calcium 1 Radiotherapy 1 Radiation 1 Midazolam 1 Ifosfamide 1 Doxorubicin 1 Digoxin 1 Dacarbazine 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03016819 2026-02-25

APROMISS

Advenchen Laboratories, LLC

Phase 3 Recruiting

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡